Renal cell carcinoma with synchronous ipsilateral urothelial carcinoma of the renal pelvis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28588718)

Published in Oncol Lett on April 04, 2017

Authors

Qun Lu1, Junlong Zhuang1, Hongqian Guo1

Author Affiliations

1: Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu 210008, P.R. China.

Articles cited by this

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A (2009) 7.95

EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol (2015) 5.10

The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol (2012) 2.83

Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm. Eur Urol (2007) 1.88

Multiple primary malignancies in renal cell carcinoma. J Urol (1998) 1.83

Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol (2003) 1.63

Synchronous ipsilateral conventional renal cell and transitional cell carcinoma. Int Urol Nephrol (2004) 1.39

Synchronous ipsilateral renal cell carcinoma and urothelial carcinoma of the renal pelvis. Can Urol Assoc J (2009) 1.27

Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology (2010) 1.25

Cancer stem cells in bladder cancer: a revisited and evolving concept. Curr Opin Urol (2010) 1.23

Renal cell carcinoma of the kidney with synchronous ipsilateral transitional cell carcinoma of the renal pelvis. Case Rep Urol (2013) 1.16

Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line. PLoS One (2013) 1.11

Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells. Immunotherapy (2010) 1.07

Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas. Int J Cancer (2014) 1.01

ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder. Asian Pac J Cancer Prev (2014) 0.94

Renal collision tumour of papillary cell carcinoma and chromophobe cell carcinoma with sarcomatoid transformation: A case report and review of the literature. Can Urol Assoc J (2014) 0.88

Diagnosis and management of upper tract urothelial carcinoma. Minerva Urol Nefrol (2014) 0.83

Ipsilateral synchronous renal pelvic transitional cell carcinoma, squamous cell carcinoma and adenocarcinoma. Chin Med J (Engl) (2004) 0.78